Live from the NIH registry
Studies recruiting near Canton right now
Top 25 of 306 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Aultman Health Foundation — Canton, Ohio (0.8 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2
Interventional 360 participants sought
Seaport Investigator Site — North Canton, Ohio (5.0 mi)
· Sponsor: Seaport Therapeutics
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Aultman Hospital — Canton, Ohio (0.8 mi)
· Sponsor: Eli Lilly and Company
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Yanke Bionics - W Exchange St — Akron, Ohio (20.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Summa Health System - Barberton Campus — Barberton, Ohio (18.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Plasma Cell Myeloma Refractory
Phase 2
Interventional 64 participants sought
Gabrail Cancer Center- Site Number : 8400010 — Canton, Ohio (0.8 mi)
· Sponsor: Sanofi
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Canton, Ohio (0.8 mi)
· Sponsor: Enveda Therapeutics
Yoga for Black and Brown Women Who Have Experienced Abuse From an Intimate Partner
Intimate Partner Violence (IPV), Psychological Well Being
Phase 1
Interventional 40 participants sought
the University of Akron — Akron, Ohio (20.5 mi)
· Sponsor: The University of Akron
A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain
Chronic Pain, Pain
Phase 2
Interventional 45 participants sought
001127 — North Canton, Ohio (5.0 mi)
· Sponsor: Adneuris Therapeutics, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Cleveland Clinic Mercy Hospital — Canton, Ohio (0.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Summa Health Clinical Research Center - Specialty — Akron, Ohio (20.5 mi)
· Sponsor: Pfizer
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Colonic Neoplasms, Neoplasms, Colon
Phase 3
Interventional 892 participants sought
GSK Investigational Site — Akron, Ohio (20.5 mi)
· Sponsor: GlaxoSmithKline
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Solid Tumor
Phase 1
Interventional 130 participants sought
Gabrail Cancer & Research Center — Canton, Ohio (0.8 mi)
· Sponsor: Sairopa B.V.
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Phase 3
Interventional 600 participants sought
Gabrail Cancer Center — Canton, Ohio (0.8 mi)
· Sponsor: Janssen Research & Development, LLC
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Akron, Ohio (20.5 mi)
· Sponsor: GlaxoSmithKline
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: Novartis Pharmaceuticals
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
University Hospitals Sharon Health Center — Wadsworth, Ohio (24.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Multiple Myeloma
Phase 1, Phase 2
Interventional 123 participants sought
GSK Investigational Site — Canton, Ohio (0.8 mi)
· Sponsor: GlaxoSmithKline
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
N/A
Observational 100 participants sought
Summa Health System - Akron - 75 Arch Street — Akron, Ohio (20.5 mi)
· Sponsor: Innoviva Specialty Therapeutics
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: National Cancer Institute (NCI)
Stepped Approach to Reducing Risk of Suicide in Primary Care
Suicidal Ideation, Suicide, Attempted
N/A
Interventional 2,572 participants sought
AxessPointe Community Health Centers/Health Quarters — Akron, Ohio (20.5 mi)
· Sponsor: Cynthia Fontanella
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Diabetes and Endocrinology Associates of Stark County Inc /ID# 256751 — Canton, Ohio (0.8 mi)
· Sponsor: AbbVie
Investigations of Reproductive Cancers in Women
Uterine Cancer
N/A
Observational 4,500 participants sought
Summa Health — Akron, Ohio (20.5 mi)
· Sponsor: PinkDx, Inc.
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
Advanced Solid Tumors, Hematologic Malignancies
Phase 1
Interventional 24 participants sought
Gabrail Cancer Center — Canton, Ohio (0.8 mi)
· Sponsor: Acrotech Biopharma Inc.
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Relapsed Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma
Phase 2
Interventional 102 participants sought
Gabrail Cancer Center Research — Canton, Ohio (0.8 mi)
· Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)